HyHeat · Profiling gene expression in Hydra vulgaris following Gold Nanoparticle-mediated hyperthermia
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2015-09-01 → 2017-08-31
- Финансиране от ЕС
- 180 277 €
- Участници
- 1
- Схема
- MSCA-IF-EF-ST
Линиите свързват координатора с партньорите.
Накратко на български
Златните наночастици се тестват върху хидра, за да се види как светлината от лазер ги загрява и как клетките реагират на този топлинен стрес. Това помага за разбирането на молекулярните механизми, което може да подобри ефективността на топлинната терапия при рак.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Profiling gene expression in Hydra vulgaris following Gold Nanoparticle-mediated hyperthermia
Hyperthermia (HT) is currently used as a non-invasive technique for cancer therapy, whereby biological tissues are exposed to higher than normal temperatures, for selective ablation of tumoral cells. Heating treatments can be applied using external heating sources such as ultrasounds, however, heating only malignant cells selectively is difficult to obtain, and therefore the translation of this modality to the clinic is still challenging. Recently, there has been a growing interest in the use of gold nanoparticles (AuNPs) to selectively generate heat in a spatiotemporal fashion, which is known as photothermal therapy (PTT). The rationale for such therapy is based on the fact that metallic NPs can be synthetized to absorb incident light coming from a laser outside the body and generate heat only in the tissues where NPs are allocated. Moreover, AuNPs are highly biocompatible and can be finely tuned to absorb light in the near-infrared (NIR) spectral range, known as the “biological window” (690-1100 nm). In this range tissue is maximally transparent, and therefore, the light itself would not damage the tissue. While significant efforts have been made to develop suitable NPs with appropriate heating capabilities, to date, the molecular mechanisms underlying the in vivo cellular responses to heat stress remain unclear. Therefore, the overall aim of the HyHeat project is to use an invertebrate model (Hydra vulgaris) to screen the heating capabilities of different AuNPs in vivo, with the grand aim of understanding the cellular responses to heat stress and therefore taking the first steps towards improving nanoparticle mediated HT efficacy for therapeutic purposes. A simple invertebrate organism have been used, in line with European strategies aimed to reduce vertebrate experimentation. During the project, we have synthesized different types of AuNPs and fully characterized them. The toxicity in the animals have been assessed using different techniques, before proceeding to laser irradiation. Lastly, gene expression profiling after laser irradiation in Hydra has been performed. It has been possible to characterize the heating capabilities of the AuNPs in vivo and select deregulated genes upon irradiation.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Hyperthermia (HT) is currently used as a non-invasive technique for cancer therapy, whereby biological tissues are exposed to higher than normal temperatures, for selective ablation of tumoral cells. However, the molecular mechanisms underlying the in vivo cellular responses to heat stress remain unclear to date. The overall aim of the HyHeat project is to use an invertebrate model to screen the heating capabilities of different gold nanoparticles (AuNPs) in vivo, with the grand aim of understanding the cellular responses to heat stress and therefore taking the first steps towards improving nanoparticle (NP) mediated HT efficacy for therapeutic purposes. To this end, plasmonic AuNPs with photothermal capabilities will be surface engineered and supplied to living Hydra by soaking. Upon laser irradiation of the animal, cellular and molecular expression will be profiled to monitor the overall response to NP-mediated HT. A simple invertebrate organism will be used, in line with European strategies aimed to reduce vertebrate experimentation. Once a panel of upregulated genes have been identified, the research will be conducted in mice analyzing those genes found deregulated in Hydra with the final aim to identify genetic markers of HT treatment and speed up the entry of this therapy into clinics. HyHeat is a multidisciplinary project that take advantage of the Fellow´s Dr. Maria Moros knowledge in the synthesis and functionalization of NPs, and the expertise of the host group supervisor (Dr. C. Tortiglione, Instituto di Cibernetica “Eduardo Caianiello” (ICIB), National Research Council (CNR), Italy) in molecular biology using invertebrate models. This project will offer the applicant the possibility to work in a top European institution who pioneered the use of Hydra to test bioactivity and toxicity of NPs, and to develop new skills and knowledge necessary for the progress of her scientific career towards an independent position.
Оригинален текст от CORDIS (на английски).
Участници
- CONSIGLIO NAZIONALE DELLE RICERCHE · RomaКоординаторИталия
Връзки
Данни: CORDIS, © Европейски съюз
